Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-12

Clinical Trial Update: Safety, Tolerability and Efficacy of the Nicotine Patch and Gum for the Treatment of Adolescent Tobacco Dependence [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial assessed safety, tolerability, and efficacy of nicotine patch and nicotine gum for treating tobacco dependence in adolescen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NICORETTE (Nicotine polacrilex)
  • Nicoderm CQ (nicotine patch)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Tobacco Dependence | Phase 2, Phase 3 | Status: COMPLETED